Carboplatin and Temozolomide (Temodar) for Recurrent and Symptomatic Residual Brain Metastases
Clinical trial NCT00362817 · COMPLETED
Trial details
- NCT number
- NCT00362817
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2008-01-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.